Treatment principles for osteochondral lesions in foot and ankle

Hygeia Hospital Orthopaedic Department, Athens, Greece.
International Orthopaedics (Impact Factor: 2.02). 08/2013; 37(9). DOI: 10.1007/s00264-013-2076-1
Source: PubMed

ABSTRACT Osteochondral lesion of the talus (OLT) is a broad term used to describe an injury or abnormality of the talar articular cartilage and adjacent bone. A variety of terms have been used to refer to this clinical entity, including osteochondritis dissecans (OCD), osteochondral fracture and osteochondral defect. Whether OLT is a precursor to more generalised arthrosis of the ankle remains unclear, but the condition is often symptomatic enough to warrant treatment. In more than one third of cases, conservative treatment is unsuccessful, and surgery is indicated. There is a wide variety of treatment strategies for osteochondral defects of the ankle, with new techniques that have substantially increased over the last decade. The common treatment strategies of symptomatic osteochondral lesions include nonsurgical treatment, with rest, cast immobilisation and use of nonsteroidal anti-inflammatory drugs (NSAIDs). Surgical options are lesion excision, excision and curettage, excision combined with curettage and microfracturing, filling the defect with autogenous cancellous bone graft, antegrade (transmalleolar) drilling, retrograde drilling, fixation and techniques such as osteochondral transplantation [osteochondral autograft transfer system (OATS)] and autologous chondrocyte implantation (ACI). Furthermore, smaller lesions are symptomatic and when left untreated, OCDs can progress; current treatment strategies have not solved this problem. The target of these treatment strategies is to relieve symptoms and improve function. Publications on the efficacy of these treatment strategies vary. In most cases, several treatment options are viable, and the choice of treatment is based on defect type and size and preferences of the treating clinician.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Osteochondral defects (OCDs) of the talus are an increasingly recognized common injury, and may occur in up to 50% of acute ankle sprains and fractures. There is a consensus regarding non-operative management of asymptomatic OCDs of the talus. Surgery is often indicated in symptomatic cases and multiple techniques have been proposed, each with specific advantages and disadvantages. Acute OCDs are usually treated by excision particularly if the fragment is small, displaced, or comminuted. If the fragment is large with a cartilage surface intact, repair may be attempted, particularly with an antero-lateral location. In chronic lesions, most authors consider non-operative management as the standard first-line approach for non-displaced lesions. Initial surgical treatment usually consists of debridement, curettage or microfracture to obtain a stable bleeding base. Failed initial debridement is an indication for resurfacing, with osteo articular cartilage transfer or mosaicplasty, autologous chondrocyte implantation, or similar techniques utilizing cartilage fragments or scaffolds performed as initial options. Generally, osteochondral allograft transplantation is considered as a salvage procedure, or for large lesions with significant bone loss that cannot be treated successfully with other resurfacing techniques.
    Operative Techniques in Sports Medicine 12/2014; 22(4). DOI:10.1053/j.otsm.2014.09.006 · 0.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The restoration and reconstruction of osseous defects close to the joint, constitutes a challenging field for reconstructive surgery. A dual-layer implant of β-tricalcium phosphate (TCP) and a collagens I/III scaffold was evaluated in a prospective, randomized comparison in a larger animal model. For this purpose, a standardized osteochondral defect was created in the medial facet of the patellar groove in both stifle joints of Göttingen minipigs. Critical-size osseous defects were either left empty (spontaneous healing; group 1; n = 12) or treated with the two-layer TCP collagen implant (group 2; n = 12). In group 3 (n = 12), additional growth factor mixture (GFM) was supplemented (bone morphogenetic proteins 2, 3, 4, 6, 7, and TGF-β1, 2, 3). Osseous defect regeneration was assessed at 6, 12, and 52 weeks postoperatively (n = 4). Qualitative and quantitative histomorphometric assessment of defect regeneration and bone substitute resorption was conducted by means of light microscopy, fluorescence microscopy, and microradiography. Critical-size defects did not heal spontaneously throughout follow-up (group 1: max. 21.84 ± 2.81% defect area at 52 weeks). The TCP layer of the implant significantly increased the amount of new bone formation with 29.8 ± 9.68% at 6 weeks and 40.09 ± 4.76% at 12 weeks when compared with controls. After 52 weeks, the TCP was almost fully degraded (4.35 ± 3.70%) and the defect was restored with lamellar trabecular bone (31.28 ± 5.02%). Growth factor supplementation resulted in earlier resorption of the TCP implant and faster defect regeneration. The dual-layer TCP collagen implant is suitable to restore subchondral osseous defects. Additional use of GFM increased the resorption of the TCP layer, but did not foster new bone formation. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.
    Journal of Biomedical Materials Research Part B Applied Biomaterials 07/2014; 102(5). DOI:10.1002/jbm.b.33074 · 2.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Osteochondral lesions of the talus (OLT) are commonly associated with traumatic injury to the ankle joint. Treatment options depend on the grade, location, and size of the lesion. Operative intervention is frequently required with initial management involving marrow stimulation techniques, such as microfracture/curettage. Larger lesions often require a secondary procedure, such as osteochondral transplantation or autologous chondrocyte implantation. The advent of particulated juvenile articular cartilage (PJAC) provides an alternative method for OLTs refractory to traditional treatments. This article describes the technique of PJAC transplantation for the treatment of osteochondral lesions of the talus.
    Foot & Ankle International 09/2014; DOI:10.1177/1071100714548704 · 1.63 Impact Factor